AIGEN INVESTMENT MANAGEMENT, LP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2022$1,302,460
-2.1%
83,491
-11.9%
0.18%
-17.5%
Q2 2022$1,330,000
+277.8%
94,747
+285.8%
0.22%
+265.6%
Q1 2022$352,000
+4.5%
24,556
-1.1%
0.06%
+190.5%
Q4 2021$337,000
-44.8%
24,820
-31.6%
0.02%
-80.2%
Q2 2021$610,000
-17.0%
36,261
-9.9%
0.11%
+9.3%
Q1 2021$735,000
-75.5%
40,250
-75.9%
0.10%
-74.7%
Q2 2020$2,996,000
+501.6%
167,092
+409.5%
0.38%
+481.8%
Q1 2020$498,000
+3.8%
32,796
+34.8%
0.07%
-16.5%
Q4 2019$480,00024,3280.08%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders